Faculty researchers from the University of Maryland, Baltimore and Johns Hopkins University and entrepreneurs building companies based on technologies from these institutions were recognized this week for their groundbreaking research with $200,000 in prizes. The awards were made by the two universities, the Abell Foundation and the Maryland Department of
On April 28, the InvestMaryland Challenge will award more than $750,000 in prizes and crown four new winners. Those top companies will be chosen from a dozen finalists and awarded $100,000 top prizes, one each in IT, Life Sciences, Sustainability & Exploration, and Defense & Security. More than $350,000 in
Ebola, HIV, influenza, malaria and tuberculosis: These and other deadly diseases could someday be globally eradicated by vaccines. This is the mission of many in Maryland’s life sciences community who will participate in the upcoming Atlantic Vaccines and Immunotherapeutics Summit, May 7-8 in Bethesda, Maryland. Organized by the Tech Council of Maryland,
February 2015 Bio Pulse: Insights on Maryland’s fight against Ebola Tim La Valle is Director of the Office of General Services at the Maryland Department of Business and Economic Development.
Maryland, a long-established hub for medical technology, is helping to grow the next generation of life sciences companies. Five companies and a research team were awarded $865,000 by the BioMaryland Center within the Maryland Department of Business and Economic Development (DBED), the BioMaryland Center announced Wednesday.
Home to both the National Institutes of Health and the Food and Drug Administration, it’s no surprise that Maryland is a vaccine industry hub. Over a dozen vaccine companies, varying in size and focus, are established in the State. But experts say the draw for these and other life sciences companies runs even deeper. In
As the Ebola virus continues to spread throughout West Africa, a number of Maryland companies are contributing aid to those impacted by the deadly disease. The Maryland Department of Business and Economic Development (DBED) and its BioMaryland Center, along with sister State agencies, the life sciences community and several non-profit organizations, are urging increased participation
Emergent BioSolutions, a global specialty biopharmaceutical company, is expanding its Baltimore manufacturing facility on Lombard Street. The announcement was made today in a release by the Maryland Department of Business and Economic Development (DBED). The expansion is slated to potentially double the company’s 58,000 square-foot space and is expected to add
Maryland companies are on the forefront of healthcare innovation, and the Maryland Department of Business and Economic Development (DBED) is helping them share their technology with the world.
Hours after online registration opened for Maryland’s Biotechnology Investment Incentive Tax Credit on Tuesday, more than 100 investors had applied. Applicants are seeking a portion of the $12 million available in FY 2015 through the program. Funding is distributed as a refundable tax credit equal to 50 percent of an investment in Qualified Maryland